↓ Skip to main content

Cochrane Database of Systematic Reviews

Amitriptyline versus placebo for major depressive disorder

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
facebook
3 Facebook pages
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
55 Dimensions

Readers on

mendeley
199 Mendeley
Title
Amitriptyline versus placebo for major depressive disorder
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd009138.pub2
Pubmed ID
Authors

Claudia Leucht, Maximilian Huhn, Stefan Leucht

Abstract

Amitriptyline is a tricyclic antidepressant that was synthesised in 1960 and introduced as early as 1961 in the USA, but is still regularly used. It has also been frequently used as an active comparator in trials on newer antidepressants and can therefore be called a 'benchmark' antidepressant. However, its efficacy and safety compared to placebo in the treatment of major depression has not been assessed in a systematic review and meta-analysis.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 199 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Germany 2 1%
Unknown 195 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 19%
Researcher 32 16%
Student > Bachelor 23 12%
Student > Ph. D. Student 15 8%
Student > Postgraduate 12 6%
Other 37 19%
Unknown 42 21%
Readers by discipline Count As %
Medicine and Dentistry 73 37%
Psychology 19 10%
Nursing and Health Professions 14 7%
Agricultural and Biological Sciences 11 6%
Social Sciences 10 5%
Other 22 11%
Unknown 50 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2018.
All research outputs
#4,615,967
of 17,455,239 outputs
Outputs from Cochrane database of systematic reviews
#6,995
of 11,689 outputs
Outputs of similar age
#62,854
of 265,241 outputs
Outputs of similar age from Cochrane database of systematic reviews
#322
of 505 outputs
Altmetric has tracked 17,455,239 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 11,689 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.1. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,241 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 505 others from the same source and published within six weeks on either side of this one. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.